Growing community of inventors

Beijing, China

Lanlan Xu

Average Co-Inventor Count = 6.00

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 387

Lanlan XuQi Liu (7 patents)Lanlan XuTong Zhang (7 patents)Lanlan XuKang Li (7 patents)Lanlan XuJing Song (7 patents)Lanlan XuHao Peng (7 patents)Lanlan XuHao Peng (1 patent)Lanlan XuTong Zhang (1 patent)Lanlan XuQi Liu (1 patent)Lanlan XuQi Liu (0 patent)Lanlan XuKang Li (1 patent)Lanlan XuJing Song (1 patent)Lanlan XuLanlan Xu (7 patents)Qi LiuQi Liu (100 patents)Tong ZhangTong Zhang (87 patents)Kang LiKang Li (32 patents)Jing SongJing Song (15 patents)Hao PengHao Peng (11 patents)Hao PengHao Peng (1 patent)Tong ZhangTong Zhang (1 patent)Qi LiuQi Liu (1 patent)Qi LiuQi Liu (0 patent)Kang LiKang Li (1 patent)Jing SongJing Song (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Beigene Switzerland Gmbh (4 from 22 patents)

2. Beigene, Ltd. (3 from 52 patents)


7 patents:

1. 11673951 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

2. 11186637 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

3. 10519235 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

4. 9988450 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

5. 9834606 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

6. 9217034 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

7. 8735553 - Anti-PD1 antibodies and their use as therapeutics and diagnostics

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/24/2025
Loading…